Camden Asset Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
Camden Asset Management's BSX.PRA Position: Q4 2022 in Review
Camden Asset Management sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q4 2022, closing a stake of 40,000 shares — an estimated $4.09M sold.
Camden Asset Management first reported a position in BSX.PRA in Q2 2020 and held it in 2 quarters. The position peaked at $37.3M in Q2 2020. 57 funds tracked by Wall St. Rank hold BSX.PRA as of Q4 2022.
- Camden Asset Management reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q4 2022 after selling out during the quarter.
- Camden Asset Management sold 40,000 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q4 2022, an estimated $4.09M.
- Camden Asset Management first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 2 quarters.
- Camden Asset Management's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $37.3M in Q2 2020.
- 57 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q4 2022.
Based on Camden Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.